German Skin Cancer Center

About

Skin cancer is the most common form of cancer worldwide, accounting for over 40% of all cancer cases. It occurs when the cells in the outermost layer of the skin begin to grow uncontrollably. This outer layer, known as the epidermis, consists of three primary cell types: squamous cells, basal cells, and melanocytes. The type of skin cancer is determined by the specific cell in which the abnormal growth begins.

• Basal cell carcinoma (BCC) is the most common type of skin cancer. It typically grows slowly and rarely spreads to other parts of the body. However, if left untreated, it can invade and destroy nearby tissues, including bone.

• Squamous cell carcinoma (SCC) is the second most common type. It tends to grow more quickly than BCC and carries a higher risk of metastasis. Like BCC, SCC can also invade underlying muscle and bone if not treated promptly.

Together, basal cell carcinoma and squamous cell carcinoma are referred to as non-melanoma skin cancers.

• Melanoma, although less common than non-melanoma types, is significantly more dangerous. It arises from the melanocytes—the pigment-producing cells in the skin—and can spread rapidly to other parts of the body. If detected early, melanoma is highly treatable, with cure rates exceeding 95%.

Over 90% of skin cancer cases are linked to exposure to ultraviolet (UV) radiation, primarily from sunlight. Preventive measures such as sun protection and regular skin checks are essential for reducing the risk of developing skin cancer.

Certain risk factors can significantly increase an individual’s likelihood of developing skin cancer. These include:

• Fair skin

• Light-colored eyes

• Light-colored or red hair

• A tendency to burn rather than tan

• A history of severe or blistering sunburns

• Numerous moles

• Presence of freckles

• A family history of skin cancer

The global incidence of both non-melanoma and melanoma skin cancers has risen dramatically over recent decades. Each year, an estimated 2 to 3 million non-melanoma skin cancers and approximately 132,000 melanoma cases are diagnosed worldwide. Skin cancer now accounts for one in every three cancer diagnoses, and according to the Skin Cancer Foundation, one in five people will develop skin cancer during their lifetime.

Given these alarming trends, regular skin checks, early detection, and prompt treatment are essential. Fortunately, when detected early, skin cancer is highly treatable and often curable.

Skin Cancer Services at GMI

At GMI, we are proud to offer a dedicated Skin Cancer Center, focused exclusively on the diagnosis, treatment, and long-term management of skin cancer. The center is led by a board-certified dermatologist with advanced expertise in skin cancer care.

We use state-of-the-art diagnostic equipment, and every suspected case is confirmed through a skin biopsy to ensure diagnostic accuracy. Our dermatology team works closely with colleagues from surgical oncology, radiation oncology, and medical oncology to develop personalized treatment plans for each patient, following GMI’s signature multidisciplinary approach to care.

Departments Involved

Main Departments

Dermatology

Plastic Surgery

Radiation Oncology

Medical Oncology

Cooperative Departments

General Surgery

German Diagnostic Center

German Internal Medicine Center

German Center of Patient Support

Diagnostic Services

At the GMI Skin Cancer Center, our team of highly specialized professionals is committed to the early detection and accurate diagnosis of skin cancer.

Dermatoscopic Evaluation

Using a dermatoscope—a handheld device that magnifies skin lesions up to 10 times—our expert dermatologists assess the color, structure, and specific features of each lesion. Dermatoscopy allows for the identification of skin cancers that may not be visible to the naked eye. In experienced hands, it is an essential tool for early and accurate diagnosis.

AI-Enhanced Total Body Mapping

Our dermatology department is equipped with a state-of-the-art system for automated total body mapping. This advanced technology combines digital dermoscopy with artificial intelligence to photograph and document all moles across the body. The system identifies suspicious, new, or changing lesions quickly and precisely.

Each mole can be magnified for detailed analysis, and the images are stored securely for comparison over time. During follow-up visits, this allows clinicians to track any changes in existing moles or detect the emergence of new ones, significantly improving early detection and long-term monitoring.

Skin Biopsy

If a suspicious lesion is identified, a skin biopsy is performed by our surgical dermatologist. This minor outpatient procedure is done under local anesthesia and typically takes only a few minutes. The lesion is removed, the wound is closed with sutures, and a simple dressing is applied.

The tissue sample is then sent to our histopathology laboratory, where it undergoes detailed cellular and molecular analysis. This provides a definitive diagnosis and helps guide any necessary follow-up treatment.

Treatment Services

The treatment approach is determined based on the pathology report, which outlines the type, characteristics, and aggressiveness of the diagnosed skin cancer. At GMI, we follow the latest national and international clinical guidelines in all treatment decisions.

Multidisciplinary Tumor Board

We adopt a comprehensive multidisciplinary approach, with dermatologists, surgical oncologists, radiation oncologists, and medical oncologists meeting weekly to review each case. This ensures that every patient benefits from a personalized, evidence-based treatment plan.

Comprehensive In-House Diagnostics

Our facility is equipped with advanced imaging technologies including PET/CT and MRI scanners, enabling complete staging, management, and monitoring of each patient’s cancer journey—all under one roof.

Tailored Treatment Plans

Treatment options vary based on the type and stage of the cancer and may include:

• Advanced skin surgery

• Radiotherapy

• Chemotherapy

• Immunotherapy

• Targeted therapies for advanced or metastatic disease

At the GMI Skin Cancer Center, we are committed to supporting you through every step of your diagnosis, treatment, and follow-up care. Our goal is to ensure the highest standard of medical care with compassion, precision, and dedication.

FAQ